GGrantIndex
← Search

PLANNING AND EVALUATION (Core 001)

$5,001P30FY2018CANIH

Wayne State University, Detroit MI

Investigators

Linked publications, trials & patents

Trial NCT06501040Trial NCT04479267Trial NCT04397679Trial NCT04266522Trial NCT04159896Trial NCT03875053Trial NCT03683420Trial NCT03456804Trial NCT03454529Trial NCT03453489Trial NCT03406858Trial NCT03252600Trial NCT03147885Trial NCT02824029Trial NCT02819024Trial NCT02723604Trial NCT02620865Trial NCT02568449Trial NCT02521090Trial NCT02520115Trial NCT02472275Trial NCT02470559Trial NCT02359019Trial NCT02178436Trial NCT02178163Trial NCT02173093Trial NCT02145078Trial NCT02094872Trial NCT02058706Trial NCT02037256Trial NCT01987596Trial NCT01958372Trial NCT01698658Trial NCT01504711Trial NCT01281163Trial NCT01175980Trial NCT01147016Trial NCT01116232Trial NCT01071564Trial NCT01051570Trial NCT01022138Trial NCT00984919Trial NCT00972023Trial NCT00942422Trial NCT00938626Trial NCT00935090Trial NCT00918762Trial NCT00914147Trial NCT00906503Trial NCT00903214Trial NCT00899665Trial NCT00897910Trial NCT00897741Trial NCT00897494Trial NCT00897247Trial NCT00890617Trial NCT00888654Trial NCT00769288Trial NCT00768118Trial NCT00717535Trial NCT00691015Trial NCT00559897Trial NCT00541099Trial NCT00527124Trial NCT00521261Trial NCT00520767Trial NCT00514215Trial NCT00503841Trial NCT00499694Trial NCT00482846Trial NCT00459121Trial NCT00438204Trial NCT00423826Trial NCT00410904Trial NCT00376948Trial NCT00369109Trial NCT00305747Trial NCT00303901Trial NCT00301808Trial NCT00293384Trial NCT00288028Trial NCT00258466Trial NCT00258310Trial NCT00258284Trial NCT00258245Trial NCT00258232Trial NCT00248560Trial NCT00248482Trial NCT00244946Trial NCT00244933Trial NCT00243048Trial NCT00238329Trial NCT00227721Trial NCT00217581Trial NCT00121264Trial NCT00118157Trial NCT00078923Trial NCT00068653Trial NCT00066326Trial NCT00056004

Abstract

PLANNING AND EVALUATION: ABSTRACT The Center's vision, set by Dr. Bepler, the Center Director, is ?to be a world leader in cancer care, research, and education through courage, commitment and compassion.? The Cancer Center Executive Committee (CCEC) leads the strategic planning activities responsible for meeting that vision. This committee, comprised of the Center Director, Deputy Center Director, Associate Center Directors, and Program Leaders, meets semi- monthly to execute the strategic planning process in support of the vision. The established process followed by the CCEC includes evaluating the Programs and Cores to ensure all activities are mission driven. Additional committees, internal to the Cancer Center ? appointed by the Center Director at the recommendation of the CCEC -- provide the communication feedback loops to guarantee critical issues are elevated to the CCEC for review. These internal committees stimulate scientific inquiry and refine the focus on the scientific direction of the Programs and Cores. Our External Advisory Board (EAB) provides objective evaluation and advice to the Center Director. Their recommendations suggest mid-course corrections to help strengthen our research. Our EAB members are experts in fields of scientific inquiry that complement our Center's focus. In addition to annual EAB meetings and regular internal planning and evaluation meetings, during the last review period, the Cancer Center held two full-day, off-campus scientific retreats to evaluate our scientific trajectory. The outcome of the first retreat, held February, 2012, was the re-organization of our scientific Programs and the identification of key scientific themes. The scientific Programs were chosen after careful consideration to our catchment area and the unique challenges posed by our market. Retreat attendees ultimately agreed on aggregating the key scientific themes into four Programs: Tumor Biology and Microenvironment, Molecular Imaging, Molecular Therapeutics, and Population Studies and Disparities Research. The second retreat, held May 5, 2014, identified strategic areas of focus for the coming five years. These areas of focus include: a) Comparative effectiveness research and health care economics; b) Immunotherapy; c) Tumor imaging and its integration into radiation treatment delivery with a focus on improving proton therapy; d) Hematologic malignancies; and e) Contribution of the microenvironment and tumor metabolism on metastasis formation. A broad representation of faculty attended both retreats which included senior leaders, senior and junior faculty, and faculty representatives from multiple School of Medicine departments. Planning and Evaluation activities are supported with institutional funds; no CCSG funds are requested.

View original record on NIH RePORTER →